145 related articles for article (PubMed ID: 34896059)
21. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
[TBL] [Abstract][Full Text] [Related]
22. Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age.
Demb J; Abraham L; Miglioretti DL; Sprague BL; O'Meara ES; Advani S; Henderson LM; Onega T; Buist DSM; Schousboe JT; Walter LC; Kerlikowske K; Braithwaite D;
J Natl Cancer Inst; 2020 Jun; 112(6):599-606. PubMed ID: 31593591
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.
Fajardo LL; Pisano ED; Caudry DJ; Gatsonis CA; Berg WA; Connolly J; Schnitt S; Page DL; McNeil BJ;
Acad Radiol; 2004 Mar; 11(3):293-308. PubMed ID: 15035520
[TBL] [Abstract][Full Text] [Related]
24. Cost-Effectiveness of Screening Mammography Beyond Age 75 Years : A Cost-Effectiveness Analysis.
Schousboe JT; Sprague BL; Abraham L; O'Meara ES; Onega T; Advani S; Henderson LM; Wernli KJ; Zhang D; Miglioretti DL; Braithwaite D; Kerlikowske K
Ann Intern Med; 2022 Jan; 175(1):11-19. PubMed ID: 34807717
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening.
Houssami N; Abraham LA; Kerlikowske K; Buist DS; Irwig L; Lee J; Miglioretti DL
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):946-61. PubMed ID: 23513042
[TBL] [Abstract][Full Text] [Related]
26. Comparing the performance of mammography screening in the USA and the UK.
Smith-Bindman R; Ballard-Barbash R; Miglioretti DL; Patnick J; Kerlikowske K
J Med Screen; 2005; 12(1):50-4. PubMed ID: 15814020
[TBL] [Abstract][Full Text] [Related]
27. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
Kerlikowske K; Carney PA; Geller B; Mandelson MT; Taplin SH; Malvin K; Ernster V; Urban N; Cutter G; Rosenberg R; Ballard-Barbash R
Ann Intern Med; 2000 Dec; 133(11):855-63. PubMed ID: 11103055
[TBL] [Abstract][Full Text] [Related]
28. The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
Théberge I; Vandal N; Guertin MH; Perron L
Breast Cancer Res Treat; 2019 Apr; 174(2):525-535. PubMed ID: 30564969
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of computer-aided detection in community mammography practice.
Fenton JJ; Abraham L; Taplin SH; Geller BM; Carney PA; D'Orsi C; Elmore JG; Barlow WE;
J Natl Cancer Inst; 2011 Aug; 103(15):1152-61. PubMed ID: 21795668
[TBL] [Abstract][Full Text] [Related]
30. Predicting biopsy outcome after mammography: what is the likelihood the patient has invasive or in situ breast cancer?
Weaver DL; Vacek PM; Skelly JM; Geller BM
Ann Surg Oncol; 2005 Aug; 12(8):660-73. PubMed ID: 15968496
[TBL] [Abstract][Full Text] [Related]
31. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
32. Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?
Weigel S; Hense HW; Heidrich J; Berkemeyer S; Heindel W; Heidinger O
Radiology; 2016 Mar; 278(3):707-13. PubMed ID: 26505802
[TBL] [Abstract][Full Text] [Related]
33. Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women.
Oseni TO; Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC
J Am Coll Surg; 2019 Jun; 228(6):932-939. PubMed ID: 30772444
[TBL] [Abstract][Full Text] [Related]
34. A prospective study of the use and effects of screening mammography in women aged 70 and older.
Vacek PM; Skelly JM
J Am Geriatr Soc; 2015 Jan; 63(1):1-7. PubMed ID: 25537022
[TBL] [Abstract][Full Text] [Related]
35. Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer.
Kerlikowske K; Barclay J; Grady D; Sickles EA; Ernster V
J Natl Cancer Inst; 1997 Jan; 89(1):76-82. PubMed ID: 8978410
[TBL] [Abstract][Full Text] [Related]
36. Harms of screening mammography for breast cancer in Japanese women.
Kasahara Y; Kawai M; Tsuji I; Tohno E; Yokoe T; Irahara M; Tangoku A; Ohuchi N
Breast Cancer; 2013 Oct; 20(4):310-5. PubMed ID: 22282164
[TBL] [Abstract][Full Text] [Related]
37. Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy.
Menes TS; Kerlikowske K; Lange J; Jaffer S; Rosenberg R; Miglioretti DL
JAMA Oncol; 2017 Jan; 3(1):36-41. PubMed ID: 27607465
[TBL] [Abstract][Full Text] [Related]
38. Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer.
Houssami N; Abraham LA; Miglioretti DL; Sickles EA; Kerlikowske K; Buist DS; Geller BM; Muss HB; Irwig L
JAMA; 2011 Feb; 305(8):790-9. PubMed ID: 21343578
[TBL] [Abstract][Full Text] [Related]
39. Are there racial/ethnic disparities among women younger than 40 undergoing mammography?
Kapp JM; Walker R; Haneuse S; Buist DS; Yankaskas BC
Breast Cancer Res Treat; 2010 Nov; 124(1):213-22. PubMed ID: 20204501
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of abnormal mammography results and palpable breast abnormalities.
Kerlikowske K; Smith-Bindman R; Ljung BM; Grady D
Ann Intern Med; 2003 Aug; 139(4):274-84. PubMed ID: 12965983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
